Xure 10 mg Tablet

Manufactured byUNICHEM LABORATORIES LTD
ContainsRupatadine
Description

Xure 10 mg Tablet is an effective anti-allergic medicine used to temporarily relieve the symptoms of seasonal allergies. These symptoms may include sneezing, runny nose, itchy eyes, sore throat, etc. This medicine is not recommended for use in children below 12 years of age.

Substitutes

List of substitutes for Xure 10 mg Tablet

Rupiz 10 mg Tablet
Zydus Cadila
Smarti 10 mg Tablet
Zydus Cadila

Side effects

Major & minor side effects for Xure 10 mg Tablet

  • Headache
  • Dizziness
  • Dry mouth
  • Fatigue
  • Tiredness and weakness
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Vomiting
  • Constipation
  • Rash

Uses of Xure 10 mg Tablet

What is it prescribed for?

  • Allergic Rhinitis
  • Urticaria
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time required for this medicine to show its action is not clinically established.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to rupatadine or any other inactive ingredients present along with this medicine.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
General warnings

Use in elderly patients

This medicine should be used with caution in elderly patients (age > 65 years) due to the increased risk of severe adverse effects. Close monitoring of such patients for any adverse effects may be required in some cases. Replacement with a suitable alternative may be necessary based on the clinical condition.

Use in pediatrics

This medicine is not recommended for use in patients below 12 years of age since the safety and efficacy of use are not clinically established.

QT prolongation

This medicine should be used with caution in patients with a prolonged QT interval due to the increased risk of worsening of the patient's condition. Close monitoring of such patients for any changes in QT interval may be necessary. Replacement with a suitable alternative may be required based on the clinical condition.

Driving or Operating machines

Use of this medicine may cause drowsiness or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Renal impairment

This medicine is not recommended for use in patients with a known history of renal diseases since the safety and efficacy of use are not clinically established for such patients.

Hepatic impairment

This medicine is not recommended for use in patients with a known history of liver diseases since the safety and efficacy of use are not clinically established for such patients.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

CYP3A4 inhibitors

Erythromycin

Ketoconazole

Disease interactions

Disease

Information not available.
Food interactions
Consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Lab interactions
Information not available.
Take this medicine with or without food. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by reducing a chemical substance called histamine, which is responsible for causing allergic symptoms.
Legal Status

Approved

Unknown

Approved

Approved

Classification

Category

Antihistamines

Schedule

Schedule H

Rupatadine - DrugBank [Internet]. Drugbank.ca. 2018 [cited 23 March 2018]. Available from:

https://www.drugbank.ca/drugs/DB11614

[Internet]. 2018 [cited 23 March 2018]. Available from:

https://www2.medicines.org.uk/emc/medicine/33172

[Internet]. 2018 [cited 23 March 2018]. Available from:

https://www2.medicines.org.uk/emc/PIL.33171.latest.pdf

[Internet]. Pedia-pharm.com. 2018 [cited 23 March 2018]. Available from:

http://www.pedia-pharm.com/en/wp-content/uploads/sites/3/2017/02/RUPALL-monograph-EN.pdf

[Internet]. Shijiebiaopin.net. 2018 [cited 23 March 2018]. Available from:

http://www.shijiebiaopin.net/upload/product/201221319054711.PDF
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error